NCT00947128View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
NauseaVomiting
Interventions
DRUG

Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)

DRUG

Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY